Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the 12 Stocks that Will Bounce Back According to Wall Street ...
Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...
Addressing the core issues of latency and integration in developing audio amplifiers for today’s smart cockpits.
Provexis reported a fall in interim revenue and a wider underlying operating loss for the six months ended 30 September on ...
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US ...
Provexis reported unaudited interim revenue of £364,000 for the six months to 30 September 2025, sharply lower than the prior year due to a third‑party delay in a new production run of its Fruitflow ...
Cereno Scientific (Nasdaq First North: CRNO B) ("the Company"), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, annou ...
Morning Overview on MSN
Scientists "cured" Alzheimer's in mice, are humans next?
Alzheimer’s disease has long been the nightmare diagnosis that medicine could slow at best, not stop. Now a wave of ...
Mechano-Growth Factor (MGF), often referred to as the IGF-1 Ec isoform (or IGF-1 Eb), is a splice variant of the insulin-like ...
Mohsen Baqery is a Guide Staff Writer from Turkey. With a passion for gaming that borders on obsession, Mohsen thrives on guiding fellow gamers through the most challenging obstacles while exploring ...
Many projects on these pages do clever things with video. Whether it’s digital or analogue, it’s certain our community can ...
Newron Pharmaceuticals further expands its intellectual property portfolio for Evenamide with a new EU composition of matter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback